Related Experiment Videos
Delirium tremens. Some clinical features. Part II
Acta Psychiatrica Scandinavica
|November 1, 1979
Summary
This study on delirium tremens (DT) suggests barbital treatment effectiveness is linked to alcohol cross-dependence. Patients with severe DT required less initial barbital, indicating a qualitative difference in withdrawal.
Area of Science:
- Neurology
- Pharmacology
- Addiction Medicine
Background:
- Delirium tremens (DT) is a severe alcohol withdrawal syndrome.
- Understanding the pathogenesis and effective treatment of DT is crucial.
Purpose of the Study:
- To investigate the clinical course and treatment response in patients with varying severity of delirium tremens.
- To explore the mechanism of action of barbital in treating DT.
Main Methods:
- Investigated 20 patients with grade 3 (severe) and grade 2 (less severe) delirium tremens.
- Performed serial lumbar punctures to analyze cerebrospinal fluid.
- Administered barbital and monitored clinical status using a rating scale.
Main Results:
- Cerebrospinal fluid and spinal fluid pressure were normal in all patients.
- Barbital treatment duration and total dosage were similar between groups.
- Severe DT patients needed less initial barbital, suggesting alcohol cross-dependence.
Conclusions:
- Barbital's efficacy in DT is likely due to its cross-dependence properties with alcohol.
- A qualitative difference may exist between severe withdrawal and full-blown delirium tremens.
- Suggests a potential "point of no return" in the progression of delirium tremens.